PFE conducting_phase-1_trial_of_oral_protease_inhibitor_against_COVID-19: https://www.businesswire.com/news/home/20210323005644/en PFE’s candidate is called PF-07321332. Oral protease inhibitors are ENTA’s bailiwick. I’m surprised that PFE got to this stage first.